Conley Chee Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Conley Chee is President & CEO of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of SYRS, which is worth approximately $0. The most recent transaction as insider was on Nov 18, 2024, when has been sold 134,797 shares (Common Stock) at a price of $0.2 per share, resulting in proceeds of $26,959. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Conley Chee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Open market or private sale
$26,959 $0.2 p/Share
134,797 Reduced 100.0%
0 Common Stock
Oct 31 2024
SELL
Payment of exercise price or tax liability
$18,197 $2.09 p/Share
8,707 Reduced 6.24%
130,797 Common Stock
Oct 31 2024
BUY
Exercise of conversion of derivative security
-
17,000 Added 10.86%
139,504 Common Stock
Sep 11 2024
BUY
Open market or private purchase
$85,500 $1.71 p/Share
50,000 Added 28.98%
122,504 Common Stock
Sep 10 2024
BUY
Open market or private purchase
$75,500 $1.51 p/Share
50,000 Added 40.81%
72,504 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$17,920 $5.12 p/Share
3,500 Reduced 13.46%
22,504 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
13,666 Added 34.45%
26,004 Common Stock
Nov 01 2023
SELL
Payment of exercise price or tax liability
$13,328 $2.22 p/Share
6,004 Reduced 32.73%
12,338 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
-
17,000 Added 48.1%
18,342 Common Stock
Apr 03 2023
SELL
Payment of exercise price or tax liability
$1,697 $2.58 p/Share
658 Reduced 32.9%
1,342 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 50.0%
2,000 Common Stock
CC

Conley Chee

President & CEO
Cambridge, MA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS